Skip to content

    Investment Firms in Geneva, Switzerland

    Situated in a global hub for diplomacy and finance, it has developed a venture capital ecosystem strongly oriented toward life sciences and fintech. The presence of leading international organizations and research institutions, such as CERN and the University of Geneva, provides a unique foundation for deep-tech and science-based startups. This environment attracts later-stage venture capital, particularly for companies advancing from proof-of-concept toward global scaling.

    Geneva, Switzerland's investment landscape is shaped by Biotech & Life Sciences, with 40% of its 5 investment firms focused on this sector. The most active by portfolio size are Pictet, Quan Funds, and Quadia.

    Biotech & Life Sciences dominates the investment landscape in Geneva, with 40% of investment firms focused on this sector.

    Last updated: 28 April 2026

    Investment Firms

    5

    Total Investments

    26

    Top Sector

    Biotech & Life Sciences

    Top Stage

    Series B

    Top Investment Sectors in Geneva

    The most popular sector focus among Geneva investment firms is Biotech & Life Sciences, with 2 investment firms (40%) investing in the space. This is followed by Fintech (2), E-Commerce & Marketplace (2), Healthcare (2), Climate & Energy (1).

    Investment Stages in Geneva

    Geneva investment firms are most active at the Series B stage (4 investment firms). This is followed by Series A (4), Series C (3), Series F (1), Series E (1).

    Frequently Asked Questions

    International